Header
Dataemia
Menu
Search for
Switch skin
Latest News
Cardiology
Dentistry
Surgery/Cosmetic
Neurology
AI/ML
Pharma / Biotech
Pediatrics
Biology
Gastroenterology
COVID-19 Live Stats
CPHQ
Informatics
Research
Privacy Policy
Disclaimer
Contact US
Search for
Switch skin
Sidebar
Random Article
LinkedIn
Twitter
Facebook
Header
Urovant
Latest News
July 6, 2022
157
Resumen: Urovant Sciences y Pierre Fabre Médicament firman un acuerdo de licencia exclusiva para comercializar Vibegron para el tratamiento de la vejiga hiperactiva en el Espacio Económico Europeo, Reino Unido y Suiza
Latest News
July 5, 2022
179
Urovant Sciences and Pierre Fabre Médicament Enter into Exclusive License Agreement to Commercialize Vibegron for the Treatment of Overactive Bladder in the European Economic Area, UK, and Switzerland
Latest News
May 15, 2022
173
Urovant Sciences® Presents New Data from EMPOWUR Study, Advancing Knowledge of the Treatment of Overactive Bladder at the 2022 American Urological Association Meeting
Latest News
May 15, 2022
164
Urovant Sciences® Presents Interim Data from Phase 2a Study of Investigational Novel Gene Therapy, URO-902, Supporting Safety, Tolerability, and Efficacy Endpoints at 2022 American Urological Association Meeting
Latest News
February 23, 2019
151
Urovant Sciences Enters into Flexible Agreement for up to $100 Million Debt Financing with Hercules Capital
Back to top button
Close
Search for
Close
Search for
